VIDEO: Stratifying risk for metastatic disease in breast cancer

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

So, in order to stratify the risk for metastatic disease, you know, we're really talking about patients, again, with early stage breast cancer. We're trying to counsel patients on the risk of developing distant relapse. And we use our usual clinical factors and that includes tumor size nodal status and tumor subtype, tumor subtype meaning ER-positive, triple-negative or HER2-positive. And finally, layer on top of that, the treatment that a patient receives. And all of those factors together really determine what is their risk of recurrence.